PARSIPPANY, N.J.--(BUSINESS WIRE)--May. 10, 2012--
Pacira
Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that James
Scibetta, chief financial officer of Pacira Pharmaceuticals, is
scheduled to present at the Bank of America Merrill Lynch 2012 Health
Care Conference on Thursday, May 17, 2012, at 10:40 a.m. PT at The
Encore at Wynn in Las Vegas. Mr. Scibetta is expected to present an
overview of the company.
A live audio webcast of the Pacira presentation can be accessed by
visiting the “Investors & Media” section of the company's website at investor.pacira.com.
A replay of the webcast will be archived on the Pacira website for two
weeks following the presentation date.
About Pacira
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) is an emerging specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company's current emphasis is the
development of non-opioid products for postsurgical pain control, and
its lead product, EXPAREL® (bupivacaine liposome injectable suspension),
was commercially launched in the United States in April 2012. EXPAREL
and two other commercially available products utilize the Pacira
proprietary product delivery technology DepoFoam®, a unique platform
that encapsulates drugs without altering their molecular structure and
then releases them over a desired period of time. Additional information
about Pacira is available at www.pacira.com
Source: Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.
James S. Scibetta, 973-254-3570
Chief
Financial Officer
